Federal Health Grants

This grant provides funding for short courses that aim to enhance research skills in using cognitive data to study aging and Alzheimer's disease across different countries, ultimately improving health outcomes and informing policies.

The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collaborating on a single set of integrated specific aims, culminating in data on optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of other critical knowledge and methods for interpretation of such a trial, such as clinical assessment of the engagement of an outcome-relevant target. Enhancing workforce and institutional capacity to conduct future rigorous, transdisciplinary research on chemically complex natural products must be built into the plans for research and for enhancing diverse perspectives. Achievement of the RM1 specific aims is expected to provide a strong foundation for a future highly informative clinical efficacy trial of the effects on resilience of a chemically complex natural product.This NOFO is one component of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include RFA-AT-24-008, Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01) and RFA-AT-24-007, Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), theNCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in community cancer prevention, intervention, and treatment research. Special emphasis is placed on training of clinical scientists whose career goal is to meet the needs of underserved or underrepresent ed communities for access to clinical care and participation in clinical research. The NOFO will allow the appointment ofScholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of underserved or underrepresented communitiesin cancer clinical research, as part of their research and career development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is expected to be published in April 2024 with an expected application due date in June 2024. TheNOFO will utilize theK12 activity code for Clinical Scientist Institutional Career Development Program Awards. Details of the planned NOFO are provided below.

This funding opportunity is designed to strengthen health informatics capabilities in PEPFAR-supported countries by developing a skilled workforce and enhancing digital health systems to combat HIV/AIDS and tuberculosis effectively.

This funding opportunity supports innovative and exploratory neuroscience research projects that aim to advance our understanding of neurological and mental health conditions, particularly for researchers and organizations engaged in high-risk studies without the need for extensive preliminary data.

This funding opportunity supports higher education institutions, nonprofit organizations, for-profit organizations, and local governments in establishing a Coordinating Center to implement and evaluate population genomic screening in primary care, focusing on diverse communities and actionable genetic conditions.

The USAID integrated Delivery of Tuberculosis Service (iDOTS) Activity grant is a funding opportunity offered by USAID/Nigeria for local organizations in Nigeria to implement tuberculosis services, with the selection process involving a three-phase process of concept submission, oral presentation, and full application submission.

This funding opportunity provides financial support to various organizations and institutions to improve laboratory services and health management systems for people living with HIV in Côte d'Ivoire.

This funding opportunity provides financial support to the Reagan-Udall Foundation for the FDA to enhance regulatory innovation and modernization in public health through collaboration, research, and the integration of new technologies.

This grant provides funding to organizations that will offer training and technical assistance to help improve mental health and substance use services within public safety systems across the United States.

This funding opportunity is designed for U.S. academic institutions with specialized mining programs to develop innovative technologies and research that improve the safety and effectiveness of underground mine evacuations during emergencies.

The United States Agency for International Development in Southern Africa (USAID/SouthernAfrica) is seeking Concept Papers from qualified entities to implement an activity entitledHealth Financing and Public Financial Management Systems Strengthening Activity in SouthAfrica. Eligibility for this award is not restricted. The authority for the Notice of FundingOpportunity (NOFO) is found in the Foreign Assistance Act of 1961, as amended.Subject to funding availability and at the discretion of the Agency, USAID intends to provide upto $30 million in total USAID funding over a five (5) year period through a CooperativeAgreement with the selected applicant. Eligible organizations interested in submitting a ConceptPaper are encouraged to read this NOFO thoroughly to understand the type of project sought(Section A), the application submission requirements (Sections C and D), and the evaluationprocess and merit review criteria (Section E). To be eligible for award, the applicant mustprovide all information required in this NOFO and meet eligibility standards in Section C.Concepts must be received by the date and time indicated at the top of this cover letter. Notethat USAID is not accepting full applications at this time - only Concept Papers.

This funding opportunity supports U.S. institutions conducting clinical trials on innovative regenerative medicine therapies using adult stem cells, focusing on extending research from previously funded projects.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.

The "RFI: USAID/Washington Digital Health, Information Systems, and Data Use Request for Information" grant is a request for information from interested parties about anticipated activities in digital health, information systems, and data use, but it does not guarantee a grant, contract, or cooperative agreement award from the U.S. Government.

This funding opportunity provides financial support to U.S. states for improving their juvenile justice systems through various programs focused on prevention, treatment, and rehabilitation of youth.

This funding opportunity supports Kuwait-based non-profits, educational institutions, and individuals in creating cultural and educational programs that strengthen ties between the U.S. and Kuwait, with a focus on diversity, inclusion, and shared challenges.

This funding opportunity aims to establish a centralized resource for generating and harmonizing ancient human DNA datasets to support modern genomic research, inviting diverse institutions and organizations to contribute.

This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds , including those from groups underrepresented in research areas of interest to the NHLBI. The career development will take place under the guidance of an experienced mentor in the biomedical, behavioral or clinical sciences leading to research independence. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators. This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA (see RFA-HL-22-010).